Won-Jea Cho

1.2k total citations
27 papers, 1.1k citations indexed

About

Won-Jea Cho is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Won-Jea Cho has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Organic Chemistry and 10 papers in Toxicology. Recurrent topics in Won-Jea Cho's work include Cancer therapeutics and mechanisms (15 papers), Bioactive Compounds and Antitumor Agents (10 papers) and Synthesis and biological activity (10 papers). Won-Jea Cho is often cited by papers focused on Cancer therapeutics and mechanisms (15 papers), Bioactive Compounds and Antitumor Agents (10 papers) and Synthesis and biological activity (10 papers). Won-Jea Cho collaborates with scholars based in South Korea, United States and Vietnam. Won-Jea Cho's co-authors include Thanh Nguyen Le, Eung-Seok Lee, Youngjoo Kwon, Tae Sung Kim, Sanghee Kim, Soo Hwan Kim, Jae-Kwang Lee, Tae‐Ho Lee, Hue Thi My Van and Eun‐Young Lee and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Won-Jea Cho

27 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Won-Jea Cho South Korea 20 559 508 132 116 112 27 1.1k
Denyse Bagrel France 23 433 0.8× 546 1.1× 161 1.2× 102 0.9× 58 0.5× 48 1.2k
Michel Thérien Canada 20 526 0.9× 452 0.9× 219 1.7× 69 0.6× 42 0.4× 34 1.0k
Weijia Xie China 23 817 1.5× 659 1.3× 109 0.8× 56 0.5× 63 0.6× 82 1.5k
Laurence Goossens France 19 651 1.2× 579 1.1× 206 1.6× 48 0.4× 60 0.5× 50 1.2k
William F. Hodnick United States 18 333 0.6× 585 1.2× 101 0.8× 141 1.2× 108 1.0× 25 1.1k
Jong‐Gab Jun South Korea 19 570 1.0× 587 1.2× 162 1.2× 70 0.6× 77 0.7× 98 1.3k
Han‐Yue Qiu China 19 625 1.1× 379 0.7× 102 0.8× 200 1.7× 56 0.5× 52 967
Hamed I. Ali Egypt 27 786 1.4× 675 1.3× 323 2.4× 93 0.8× 102 0.9× 60 1.6k
Burcu Çalışkan Türkiye 20 458 0.8× 252 0.5× 212 1.6× 57 0.5× 49 0.4× 51 883
Li‐Jiau Huang Taiwan 21 1.0k 1.9× 723 1.4× 164 1.2× 280 2.4× 116 1.0× 65 1.8k

Countries citing papers authored by Won-Jea Cho

Since Specialization
Citations

This map shows the geographic impact of Won-Jea Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won-Jea Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won-Jea Cho more than expected).

Fields of papers citing papers by Won-Jea Cho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won-Jea Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won-Jea Cho. The network helps show where Won-Jea Cho may publish in the future.

Co-authorship network of co-authors of Won-Jea Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Won-Jea Cho. A scholar is included among the top collaborators of Won-Jea Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Won-Jea Cho. Won-Jea Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roh, Eunmiri, Song‐Hee Kim, Jiyeon Lee, et al.. (2019). Stem Cell Factor-Inducible MITF-M Expression in Therapeutics for Acquired Skin Hyperpigmentation. Theranostics. 10(1). 340–352. 12 indexed citations
2.
Khadka, Daulat Bikram, Suhui Yang, Chao Zhao, et al.. (2015). Modification of 3-arylisoquinolines into 3,4-diarylisoquinolines and assessment of their cytotoxicity and topoisomerase inhibition. European Journal of Medicinal Chemistry. 92. 583–607. 24 indexed citations
3.
Van, Hue Thi My, Hyung Min Jeong, Daulat Bikram Khadka, et al.. (2014). Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors. European Journal of Medicinal Chemistry. 82. 181–194. 26 indexed citations
4.
Kim, Han-Jong, et al.. (2013). Scoparone Exerts Anti-Tumor Activity against DU145 Prostate Cancer Cells via Inhibition of STAT3 Activity. PLoS ONE. 8(11). e80391–e80391. 68 indexed citations
5.
Karki, Radha, Tara Man Kadayat, Eun‐Young Lee, et al.. (2012). Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety. European Journal of Medicinal Chemistry. 52. 123–136. 58 indexed citations
6.
Kim, Don‐Kyu, Dongryeol Ryu, Minseob Koh, et al.. (2012). Orphan Nuclear Receptor Estrogen-Related Receptor γ (ERRγ) Is Key Regulator of Hepatic Gluconeogenesis. Journal of Biological Chemistry. 287(26). 21628–21639. 112 indexed citations
7.
Karki, Radha, Tara Man Kadayat, Pil-Hoon Park, et al.. (2012). Dihydroxylated 2,4,6-triphenyl pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study. European Journal of Medicinal Chemistry. 49. 219–228. 68 indexed citations
9.
Kim, Eun‐Jin, Young-Sil Yoon, Suckchang Hong, et al.. (2011). Retinoic acid receptor–related orphan receptor α–induced activation of adenosine monophosphate–activated protein kinase results in attenuation of hepatic steatosis. Hepatology. 55(5). 1379–1388. 56 indexed citations
10.
Khadka, Daulat Bikram, Suhui Yang, Hue Thi My Van, et al.. (2011). Design, synthesis and docking study of 5-amino substituted indeno[1,2-c]isoquinolines as novel topoisomerase I inhibitors. Bioorganic & Medicinal Chemistry. 19(6). 1924–1929. 15 indexed citations
11.
Le, Thanh Nguyen, Suhui Yang, Daulat Bikram Khadka, et al.. (2011). Design and synthesis of 4-amino-2-phenylquinazolines as novel topoisomerase I inhibitors with molecular modeling. Bioorganic & Medicinal Chemistry. 19(14). 4399–4404. 16 indexed citations
12.
Thapa, Uttam, Radha Karki, Yurngdong Jahng, et al.. (2011). Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship. European Journal of Medicinal Chemistry. 46(8). 3201–3209. 49 indexed citations
13.
Pillaiyar, Thanigaimalai, Vinay K. Sharma, Cheonik Joo, et al.. (2011). Structural requirement of phenylthiourea analogs for their inhibitory activity of melanogenesis and tyrosinase. Bioorganic & Medicinal Chemistry Letters. 21(22). 6824–6828. 32 indexed citations
14.
Yang, Suhui, Hue Thi My Van, Thanh Nguyen Le, et al.. (2010). Development of 3-aryl-1-isoquinolinamines as potent antitumor agents based on CoMFA. European Journal of Medicinal Chemistry. 45(11). 5493–5497. 21 indexed citations
15.
Van, Hue Thi My, Kwang Youl Lee, Eung-Seok Lee, et al.. (2007). Convenient synthesis of indeno[1,2-c]isoquinolines as constrained forms of 3-arylisoquinolines and docking study of a topoisomerase I inhibitor into DNA–topoisomerase I complex. Bioorganic & Medicinal Chemistry Letters. 17(21). 5763–5767. 34 indexed citations
16.
Cho, Won-Jea, Hue Thi My Van, Kwang Youl Lee, et al.. (2007). Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(13). 3531–3534. 44 indexed citations
17.
Le, Thanh Nguyen & Won-Jea Cho. (2006). Total Synthesis of Oxyfagaronine, Phenolic Benzo[c]phenanthridine and General Synthetic Way of 2,3,7,8- and 2,3,8,9-Tetrasubstituted Benzo[c]phenanthridine Alkaloids. Chemical and Pharmaceutical Bulletin. 54(4). 476–480. 23 indexed citations
18.
Cho, Won-Jea, Sun Young Min, Thanh Nguyen Le, & Tae Sung Kim. (2003). Synthesis of new 3-Arylisoquinolinamines: effect on topoisomerase I inhibition and cytotoxicity. Bioorganic & Medicinal Chemistry Letters. 13(24). 4451–4454. 48 indexed citations
19.
Cho, Won-Jea, Il Yeong Park, Eun Young Jeong, et al.. (2002). Molecular modeling of 3-arylisoquinoline antitumor agents active against A-549. A comparative molecular field analysis study. Bioorganic & Medicinal Chemistry. 10(9). 2953–2961. 41 indexed citations
20.
Cheon, Seung Hoon, et al.. (1999). Studies on the synthesis andin vitro antitumor activity of the isoquinolone derivatives. Archives of Pharmacal Research. 22(2). 179–183. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026